Perpetua Resources Secures 29 Billion US Loan for Idaho Gold and Antimony Project Crude Oil Prices Slip as USIran Diplomatic Hopes Resurface Brent Below 96 Insurance Tech Corgi Triples Valuation to 26B in Three Weeks with 106M Funding Round Historic Fed Overlap Powell and Warsh to Coexist at June FOMC Meeting AutoNation Inc Analyst Report Highlights Sector Challenges and Opportunities Google Pixel Launch Raises Privacy Concerns Around AI Assistant Potentially Impacting Regulatory Outlook RCEL Q1 2026 Earnings EPS Misses Estimates Stock Gains Amid Operational Progress REG Q1 2026 Earnings Strong EPS Beat Drives Positive Investor Reaction Citi Trends CTRN Q1 2026 Earnings EPS Surges Past Estimates Shares Gain 253 vTv Therapeutics Inc VTVT Q1 2026 Earnings Massive EPS Surprise Despite No Revenue WGS Q1 2026 Earnings Significant EPS Miss Amidst Operational Challenges CNS Q1 2026 Earnings Earnings Miss Estimates as EPS Falls Short America Movil AMX Holds Above Key Support After Modest Decline Fox Corporation FOXA Consolidates Near Support Amid Modest Downtrend Aclaris Therapeutics Holds Steady Near MidRange as Traders Eye Key Support and Resistance QVC Group Inc QVCGA Holds Steady at 034 Cautious Trading Continues Edgewise Therapeutics EWTX Holds Steady Near Support Amid Biotech Trading Lull Mcap of Six of Top10 Most Valued Firms Surges by 74100 Crore Reliance Emerges as Biggest Gainer Dyadic International Inc DYAI Q1 2026 Earnings EPS Misses Estimates as PreRevenue Status Continues Encore Capital Group ECPG Slips 168 as Shares Test Key Support at 80 FIGS Inc Edges Higher as Stock Approaches Resistance Zone Presurance Holdings Notes PRHIZ Steady at 1744 as Market Weighs Credit and Rate Risks Watts Water Technologies WTS Rallies 273 as Shares Approach 310 Resistance Zone Insight Digital Partners II DYOR Holds Near Support Amid Low Volatility ATIF Holdings ZBAI Holds Steady at 895 Amid Neutral Trading Session Crane Harbor Acquisition Corp II Rights CRANR Drifts Sideways at 021 Support and Resistance Tighten Jasper Therapeutics JSPR Edges Higher SmallCap Biotech Tests Resistance at 095